1. Home
  2. PANDRH Documents
  3. CPANDRH
  4. IX CPANDRH

IX CPANDRH

IX Conference of the Pan American Network for Drug Regulatory Harmonization (CPANDRH)
San Salvador, El Salvador. 24 -26 October, 2018

The latest conference, IX CPANDRH, was held in San Salvador, from October 24th - 26th, 2018 with the theme "Commemorating 20 years of PANDRH and 40 years of Alma-Ata. The contributions of regulatory harmonization on achieving Health for All".

Conference News

IX CPANDRH. San Salvador, El Salvador. 24 -26 October, 2018. Recommendations

 

Twenty Years of PANDRH: A brief history of the regulatory network

More information about  The Pan American Network for Drug Regulatory Harmonization

  IX PANDRH Conference: Important documents 

Fecha
Regulatory reliance principles: concept note and recommendations. Ninth Conference of the Pan American Network for Drug Regulatory Harmonization (PANDRH) (San Salvador, 24 to 26 October, 2018)
Regulatory reliance principles: concept note and recommendations. Ninth Conference of the Pan American Network for Drug Regulatory Harmonization (PANDRH) (San Salvador, 24 to 26 October, 2018)
Agenda. IX Pan American Network for Drug Regulatory Harmonization Conference. San Salvador, El Salvador. “Regulatory Harmonization Contributions to the Achievement of Health for All” Commemorating 20 years of PANDRH and 40 years of Alma-Ata.
Presentation - Conclusions and adoption of the recommendations of the IX CPARF (only in Spanish)
(Chrystal Samouge, Ministry of Health, Belize). Publication of OTC List for General Sale: The Belize Experience.
Presentation - Interrelationship of supply chain‐access and rational use: Guyana experience (Influences of supply chain on access to medical products and rational use)
(C. Luwis, M. Freitas). PANDRH Project update: Assessing CPP requirement for medicines registration – presentation of the preliminary outcomes.
(Enrique Perez Gutierrez PAHO Department in Health Emergencies). Interaction of regulatory authorities (Ministries of Health) with those responsible for animal health.
(Fernanda Lessa . PAHO Specialist). Platforms for promoting the exchange of information between regulators.
Transparency and information for decision making: patient engagement and publication of clinical data
Presentation - Advances in the exchange of information in the Region of the Americas on global regulatory convergence initiatives
Presentation - Innovative Pharmaceutical Development Approaches require strong Regulatory Systems – An Industry Perspective
(Virigina Asins. CARPHA). CRS Status, main challenges, future outlook.
(Maria Cristina Mota. Director Regulatory Policy and Intelligence, On behalf of FIFARMA). Transparencia, responsabilidad y participación en procesos regulatorios: la interrelación de la industria con el ente regulador.
(Wilson W. Bryan. Office of Tissues and Advanced Therapies. Center for Biologics Evaluation and Research. United States Food and Drug Administration). Advanced Therapy Medicinal Products (ATMPs).
Presentation - Reliance and strengthening of regulatory systems: the EMA and Article 58
(Emer Cooke, Director, Regulation of Medicines and other Health Technologies) Improving Access to Medical Products through Strengthening Regulatory Systems.
Agenda. IX Pan American Network for Drug Regulatory Harmonization Conference